Function of C-reactive protein

被引:614
作者
Du Clos, TW
机构
[1] VA Med Ctr, Res Serv 151, Albuquerque, NM 87108 USA
[2] Univ New Mexico, Sch Med, Dept Med, Albuquerque, NM 87131 USA
关键词
acute phase response; C-reactive protein; inflammation; pentraxins;
D O I
10.3109/07853890009011772
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
C-reactive protein (CRP) is an ancient highly conserved molecule and a member of the pentraxin family of proteins. CRP is secreted by the liver in response to a variety of inflammatory cytokines. Levels of CRP increase very rapidly in response to trauma, inflammation, and infection and decrease just as rapidly with the resolution of the condition. Thus, the measurement of CRP is widely used to monitor various inflammatory states. CRP binds to damaged tissue, to nuclear antigens and to certain pathogenic organisms in a calcium-dependent manner. The function of CRP is felt to be related to its role in the innate immune system. Similar to immunoglobulin (Ig)G, it activates complement, binds to Fc rcceptors and acts as an opsonin for various pathogens. Interaction of CRP with Fc receptors leads to the generation of proinflammatory cytokines that enhance the inflammatory response. Unlike IgG, which specifically recognizes distinct antigenic epitopes, CRP recognizes altered self and foreign molecules based on pattern recognition. Thus, CRP is though to act as a surveillance molecule for altered self and certain pathogens. This recognition provides early defense and leads to a proinflammatory signal and activation of the humoural, adaptive immune system.
引用
收藏
页码:274 / 278
页数:5
相关论文
共 31 条
  • [1] INDUCTION OF INFLAMMATORY CYTOKINE RELEASE FROM CULTURED HUMAN MONOCYTES BY C-REACTIVE PROTEIN
    BALLOU, SP
    LOZANSKI, G
    [J]. CYTOKINE, 1992, 4 (05) : 361 - 368
  • [2] BERMAN S, 1986, J IMMUNOL, V136, P1354
  • [3] The major receptor for C-reactive protein on leukocytes is Fcγ receptor II
    Bharadwaj, D
    Stein, MP
    Volzer, M
    Mold, C
    Du Clos, TW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (04) : 585 - 590
  • [4] Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity
    Bickerstaff, MCM
    Botto, M
    Hutchinson, WL
    Herbert, J
    Tennent, GA
    Bybee, A
    Mitchell, DA
    Cook, HT
    Butler, PJG
    Walport, MJ
    Pepys, MB
    [J]. NATURE MEDICINE, 1999, 5 (06) : 694 - 697
  • [5] CROWELL RE, 1991, J IMMUNOL, V147, P3445
  • [6] The interaction of C-reactive protein and serum amyloid P component with nuclear antigens
    DuClos, TW
    [J]. MOLECULAR BIOLOGY REPORTS, 1996, 23 (3-4) : 253 - 260
  • [7] DUCLOS TW, 1990, J IMMUNOL, V145, P3869
  • [8] DUCLOS TW, 1981, CLIN EXP IMMUNOL, V43, P565
  • [9] DECREASED AUTOANTIBODY LEVELS AND ENHANCED SURVIVAL OF (NZB X NZW) F(1) MICE TREATED WITH C-REACTIVE PROTEIN
    DUCLOS, TW
    ZLOCK, LT
    HICKS, PS
    MOLD, C
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 70 (01): : 22 - 27
  • [10] DUCLOS TW, 1989, J IMMUNOL, V143, P2553